Identification of cytokines that might enhance the promoter activity of HLA-B27

J Rheumatol. 2008 May;35(5):862-8. Epub 2008 Mar 15.

Abstract

Objective: Although the mechanism by which HLA-B27 induces ankylosing spondylitis is unclear, a minimum threshold of transcription is essential, a process controlled at the promoter. Our aim was to scan the effect of a panel of cytokines on the promoter of the HLA-B27 gene over serial timepoints.

Methods: The promoter region of B*2705 gene was cloned into a luciferase reporter, stably transfected into HeLa cells, and used to monitor the serial effect of 25 cytokines. Results of HLA-B27 promoter-reporter assays were compared to those of real-time polymerase chain reactions.

Results: After an initial delay, significant activation of the HLA-B27 promoter was observed with tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), and IFN-beta. While early response of the HLA-B27 promoter was highest with TNF-alpha and IFN-gamma, ultimately the highest activity was observed with IFN-beta.

Conclusion: The only promoter of HLA-B alleles studied in the past was that of HLA-B7, and always at only a single fixed timepoint of culture. This is the first study to show that activation of HLA-B27 promoter is a sequential event, and that TNF-alpha and IFN-beta are major participants at different timepoints.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Base Sequence
  • Cell Line
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • HLA-B27 Antigen / genetics*
  • HLA-B27 Antigen / metabolism*
  • HeLa Cells
  • Humans
  • Interferon-beta / pharmacology*
  • Interferon-gamma / pharmacology*
  • Molecular Sequence Data
  • NF-kappa B / metabolism
  • Promoter Regions, Genetic / drug effects*
  • Promoter Regions, Genetic / genetics
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • HLA-B27 Antigen
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Interferon-beta
  • Interferon-gamma